The current stock price of PYPD is 4.78 USD. In the past month the price increased by 22.56%. In the past year, price increased by 47.53%.
ChartMill assigns a technical rating of 10 / 10 to PYPD. When comparing the yearly performance of all stocks, PYPD is one of the better performing stocks in the market, outperforming 91.46% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to PYPD. PYPD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
Over the last trailing twelve months PYPD reported a non-GAAP Earnings per Share(EPS) of -2.94. The EPS increased by 62.36% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -127.48% | ||
| ROE | -222.69% | ||
| Debt/Equity | 0 |
10 analysts have analysed PYPD and the average price target is 12.5 USD. This implies a price increase of 161.4% is expected in the next year compared to the current price of 4.78.
PolyPid Ltd. operates as a phase 3 biopharma company. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
POLYPID LTD
18 Hasivim Street, P.O Box 7126
Petah Tikva 49537 IL
CEO: Amir Weisberg
Employees: 57
Phone: 972747195700
PolyPid Ltd. operates as a phase 3 biopharma company. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.
The current stock price of PYPD is 4.78 USD. The price decreased by -0.62% in the last trading session.
PYPD does not pay a dividend.
PYPD has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
POLYPID LTD (PYPD) operates in the Health Care sector and the Pharmaceuticals industry.
POLYPID LTD (PYPD) has a market capitalization of 79.49M USD. This makes PYPD a Micro Cap stock.
POLYPID LTD (PYPD) will report earnings on 2026-02-10, after the market close.